Fennec Pharmaceuticals (FENC) Current Assets (2017 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Current Assets came in at $67.0 million in Q4 2025, up 51.94% YoY from $44.1 million in Q4 2024, and up 45.54% on a QoQ basis from $46.1 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Current Assets (2017 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 9 years of Current Assets data on file, last reported at $67.0 million in Q4 2025.
- Quarterly Current Assets rose 51.94% year-over-year to $67.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $67.0 million (up 51.94% YoY) and the FY2025 annual result came in at $67.0 million, up 51.94% from the prior year.
- Current Assets improved to $67.0 million in Q4 2025, from $46.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $68.2 million in Q1 2024 to a low of $15.6 million in Q2 2022.
- A 5-year average of $35.6 million and a median of $27.9 million in 2021 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 44.6% — and 2024, when it jumped 221.62%.
- Tracing FENC's Current Assets over 5 years: stood at $22.4 million in 2021, then rose by 19.39% to $26.7 million in 2022, then increased by 0.49% to $26.9 million in 2023, then surged by 64.29% to $44.1 million in 2024, then soared by 51.94% to $67.0 million in 2025.
- The last three Current Assets figures came in at $67.0 million (Q4 2025), $46.1 million (Q3 2025), and $40.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 72.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.50 Mn |
| Dec 31, 2025 | 67.04 Mn |
| Sep 30, 2025 | 46.06 Mn |
| Jun 30, 2025 | 40.79 Mn |
| Mar 31, 2025 | 42.98 Mn |
| Dec 31, 2024 | 44.12 Mn |
| Sep 30, 2024 | 57.97 Mn |
| Jun 30, 2024 | 62.17 Mn |
| Mar 31, 2024 | 68.17 Mn |
| Dec 31, 2023 | 26.86 Mn |
| Sep 30, 2023 | 19.90 Mn |
| Jun 30, 2023 | 19.33 Mn |
| Mar 31, 2023 | 21.66 Mn |
| Dec 31, 2022 | 26.73 Mn |
| Sep 30, 2022 | 30.15 Mn |
| Jun 30, 2022 | 15.55 Mn |
| Mar 31, 2022 | 19.13 Mn |
| Dec 31, 2021 | 22.39 Mn |
| Sep 30, 2021 | 25.98 Mn |
| Jun 30, 2021 | 28.07 Mn |